6MOA
C-terminal bromodomain of human BRD2 in complex with 4-(2-cyclopropyl-7-(6-methylquinolin-5-yl)-1H-benzo[d]imidazol-5-yl)-3,5-dimethylisoxazole inhibitor
Functional Information from PDB Data
site_id | AC1 |
Number of Residues | 11 |
Details | binding site for residue JW4 A 501 |
Chain | Residue |
A | TRP370 |
A | HOH657 |
A | HOH665 |
A | PRO371 |
A | PHE372 |
A | LEU381 |
A | LEU383 |
A | ASN429 |
A | HIS433 |
A | HOH604 |
A | HOH655 |
site_id | AC2 |
Number of Residues | 8 |
Details | binding site for residue GOL A 502 |
Chain | Residue |
A | TYR368 |
A | LYS402 |
A | ASP407 |
A | MET438 |
A | LYS441 |
A | HOH601 |
A | HOH613 |
A | HOH626 |
Functional Information from PROSITE/UniProt
site_id | PS00633 |
Number of Residues | 60 |
Details | BROMODOMAIN_1 Bromodomain signature. AwpFykpvDasalglhDYHdiIkhpMdlstVkrkmenrd..Yrdaqefaadvrl.MfsNCykY |
Chain | Residue | Details |
A | ALA369-TYR428 |